Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fouquet

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
La Revue De Medecine Interne|September 21, 2013
[Smoldering multiple myeloma]G Fouquet, S Guidez, C Herbaux, et al.
Digestive Diseases and Sciences|April 1, 1995
Effect of streptozotocin-induced diabetes mellitus on release of vasoactive intestinal polypeptide from rodent small intestineT V Nowak, W W Chey, T M Chang, et al.
Leukemia|May 26, 2012
Reduced steady state-based peripheral blood stem cell harvest rate in multiple myeloma treated with bortezomib-based induction regimensS Manier, M Barthelemy, G Fouquet, et al.
La Revue De Medecine Interne|January 19, 2015
[Monoclonal gammopathies of undetermined significance do not systematically require a specialized consultation]G Fouquet, K Amouzou, L Renaud, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 31, 2021
Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practiceG Fouquet, P Franchi, B Mittaine-Marzac, et al.
La Revue De Medecine Interne|August 11, 2015
[Pomalidomide for multiple myeloma]G Fouquet, M Macro, O Decaux, et al.
Leukemia|April 6, 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myelomaX Leleu, G Fouquet, B Hebraud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myelomaG Fouquet, B Pegourie, M Macro, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
La Revue De Medecine Interne|September 21, 2013
[Smoldering multiple myeloma]G Fouquet, S Guidez, C Herbaux, et al.
Digestive Diseases and Sciences|April 1, 1995
Effect of streptozotocin-induced diabetes mellitus on release of vasoactive intestinal polypeptide from rodent small intestineT V Nowak, W W Chey, T M Chang, et al.
Leukemia|May 26, 2012
Reduced steady state-based peripheral blood stem cell harvest rate in multiple myeloma treated with bortezomib-based induction regimensS Manier, M Barthelemy, G Fouquet, et al.
La Revue De Medecine Interne|January 19, 2015
[Monoclonal gammopathies of undetermined significance do not systematically require a specialized consultation]G Fouquet, K Amouzou, L Renaud, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 31, 2021
Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practiceG Fouquet, P Franchi, B Mittaine-Marzac, et al.
La Revue De Medecine Interne|August 11, 2015
[Pomalidomide for multiple myeloma]G Fouquet, M Macro, O Decaux, et al.
Leukemia|April 6, 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myelomaX Leleu, G Fouquet, B Hebraud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myelomaG Fouquet, B Pegourie, M Macro, et al.
Pageof 1